Prot #MDV3100-11: A Phase 2, Single-Arm, Open-Label, Multicenter Study of the Clinical Activity and Safety of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple-Negative Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date11/8/1311/8/16

Funding

  • Medivation, Inc. (Prot #MDV3100-11)